Medindia
Medindia LOGIN REGISTER
Advertisement

ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine

Wednesday, September 19, 2007 General News
Advertisement
CHARLES TOWN, W.V., Sept. 18 ReBuilder MedicalTechnologies, Inc. (Pink Sheets: RBRM) today announced the appointment ofFoot-O-Pedics to be the exclusive distributor of its ReBuilder System fordiabetic Peripheral Neuropathy in Maine.
Advertisement

(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO)

Foot-O-Pedics is a family-owned and operated business that prides itselfin providing quality products and customer service. "We will commit toadvertising the products in newspapers, TV and possibly radio," says LarryGowell, President of Foot-O-Pedics. "We will also use direct mail to inviteresidents of Maine into our offices for a free demonstration of theReBuilder."
Advertisement

David B. Phillips, Ph.D., CEO of ReBuilder Medical Technologies, Inc.said, "We are pleased to add Foot-O-Pedics to our growing line ofdistributors and exclusively in Maine. They have a fantastic reputation andwe have found that local representation and a personal demonstration lendscredibility to our older customers who suffer from pain and tingling in theirfeet."

More information can be found about Foot-O-Pedics athttp://www.footopedics.com.

About ReBuilder Medical Technologies, Inc.:

ReBuilder Medical Technologies, Inc is an emerging medical devicemanufacturer of innovative technologies founded by world renowned medicaldevice inventor David B. Phillips, Ph.D. ReBuilder Medical's flagship productis its FDA registered ReBuilder System for treating peripheral neuropathy.Unlike current therapies for neuropathy which focus on prescription drugswith powerful side effects, the ReBuilder System is a portable, batterypowered medical product that provides a new non-surgical treatment which isnon-invasive, has no side effects and can actually strengthen muscles whileincreasing blood flow.

ReBuilder Medical also manufactures the Phillips Molluscum Treatmentsystem for treating the skin disease Molluscum Contagiosum which primarilyaffects children. This system uses micronized, amorphous silver ions todisable the molluscum virus without side effects. The company is currentlyperforming research and development on a number of other products as well.

Dr. Phillips is CEO of ReBuilder Medical Technologies, Inc. located inCharles Town, WV. He is best known for inventing the very first infrared earthermometer. Dr. Phillips also was responsible for the GST System for theearly detection of breast cancer and the AcuPen, which detects acupuncturepoints and then treats them.

More information on ReBuilder Medical and its products can be found at:http://www.rebuildermedical.com.

Safe Harbor: This letter contains certain forward-looking statementswithin the meaning of Section 27A of the Securities Act of 1933, as amendedand Section 21E of the Securities Exchange Act of 1934, as amended, which areintended to be covered by the safe harbors created thereby. Investors arecautioned that all forward-looking statements involve risks and uncertainty,including without limitation, the ability of the Company to successfullyimplement its turnaround strategy, changes in costs of raw materials, labor,and employee benefits, as well as general market conditions, competition andpricing. Although the Company believes that the assumptions underlying theforward-looking statements contained herein are reasonable, any of theassumptions could be inaccurate, and therefore, there can be no assurancethat the forward-looking statements included in this letter will prove to beaccurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information shouldnot be regarded as representation by the Company or any other person that theobjectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read thosestatements. When used i
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close